ADAM33 polymorphisms and susceptibility to allergic rhinitis: a meta-analysis

Area of Science:

• Genetics
• Immunology
• Allergy Research

Background:

• Allergic rhinitis (AR) is a prevalent allergic condition.
• The role of ADAM33 gene polymorphisms in AR susceptibility has been suggested but requires clarification.

Purpose of the Study:

• To conduct a meta-analysis to determine the association between ADAM33 gene polymorphisms and AR risk.
• To clarify the impact of specific ADAM33 polymorphisms on AR susceptibility.

Main Methods:

• Systematic literature search of PubMed, EMBASE, and Cochrane Library up to October 2013.
• Meta-analysis of six studies involving 1,135 AR patients and 1,565 controls.
• Calculation of pooled odds ratios (ORs) and 95% confidence intervals (CIs) for seven ADAM33 polymorphisms (T1, T2, S1, S2, V4, Q-1, T+1).

Main Results:

• ADAM33 T1, T2, V4, and Q-1 polymorphisms showed a significant association with increased AR susceptibility.
• No significant association was found for S1, S2, and T+1 polymorphisms.
• The observed associations were consistent across different ethnicities.

Conclusions:

• ADAM33 T1, T2, V4, and Q-1 polymorphisms are identified as potential risk factors for allergic rhinitis.
• Ethnicity did not significantly alter the association between these ADAM33 polymorphisms and AR.
• Future research should explore gene-gene and gene-environment interactions in AR.